Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Fibrinogen Seattle: a qualitatively abnormal fibrinogen in a patient with tetralogy of Fallot.

Branson HE, Schmer G, Dillard DH.

Am J Clin Pathol. 1977 Mar;67(3):236-40.

PMID:
842496
2.

An abnormal fibrinogen with delayed fibrinopeptide A release.

Lane DA, VanRoss M, Kakkar VV, Bottomley KJ, Dhir K, Holt LP, MacIver JE.

Br J Haematol. 1980 Sep;46(1):89-98.

PMID:
7426452
3.

Hereditary dysfibrinogenaemia (fibrinogen Jena)--report of a family study.

Maak B.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1988;115(4):519-22.

PMID:
2465965
4.
5.

Fibrinogen Seattle II: defective release of fibrinopeptide A in a slow clotting fibrinogen.

Schreiber WE, Schmer G.

Thromb Res. 1985 Jan 1;37(1):45-52.

PMID:
3983901
6.

[Hemorrhages after radical correction of tetralogy of Fallot].

Satmari VV.

Grudn Khir. 1974;(6):74-7. Russian. No abstract available.

PMID:
4448401
7.

Haemostatic balance in patients with tetralogy of Fallot.

Amris CJ, Borgeskov S, Rygg IH.

Dan Med Bull. 1971 Jan;18:Suppl 2:119+. No abstract available.

PMID:
5546610
8.

Fibrinogen Logroño. A new case of congenital dysfibrinogenemia.

Rocha E, Lasierra J, Narvaiza MJ, Vilades E, Palacios E, Fernandez J.

Ric Clin Lab. 1984 Oct-Dec;14(4):663-72.

PMID:
6522973
9.
10.

[Tetralogy of Fallot in adults].

Soro A, Piva R, Pangrazi A, Ballerini L.

Boll Soc Ital Cardiol. 1977;22(5):705-13. Italian. No abstract available.

PMID:
618148
11.

A lower molecular weight gamma-chain variant in a congenital abnormal fibrinogen (Kyoto).

Yoshida N, Okuma M, Moroi M, Matsuda M.

Blood. 1986 Sep;68(3):703-7.

12.
13.

A new dysfibrinogenemia: fibrinogen Oslo IV.

Stormorken H, Brosstad F, Seim H.

Thromb Haemost. 1983 Apr 28;49(2):120-2.

PMID:
6868008
14.

Congenital abnormal fibrinogens.

Ménaché D.

Prog Clin Biol Res. 1981;72:205-20.

PMID:
7335649
15.

[Hereditary dysfibrinogenaemia. Study of a family (author's transl)].

Voinnesson A, Salaün M.

Sem Hop. 1979 Oct 8-15;55(33-34):1507-12. French.

PMID:
229560
16.

Twenty-to-thirty-seven-year follow-up after repair for Tetralogy of Fallot.

Nørgaard MA, Lauridsen P, Helvind M, Pettersson G.

Eur J Cardiothorac Surg. 1999 Aug;16(2):125-30.

PMID:
10485408
17.

Fibrinogen Houston: a dysfibrinogen exhibiting defective fibrin monomer aggregation and alpha-chain cross-linkages.

Weinger RS, Rudy C, Moake JL, Conlon CL, Cimo PL.

Am J Hematol. 1980;9(3):237-48.

PMID:
6165239
18.

Late risk of outcomes for adults with repaired tetralogy of Fallot from an inception cohort spanning four decades.

Hickey EJ, Veldtman G, Bradley TJ, Gengsakul A, Manlhiot C, Williams WG, Webb GD, McCrindle BW.

Eur J Cardiothorac Surg. 2009 Jan;35(1):156-64; discussion 164. doi: 10.1016/j.ejcts.2008.06.050. Epub 2008 Oct 9.

PMID:
18848456
19.

Fibrinogen New Orleans: hereditary dysfibrinogenemia with an A alpha chain abnormality.

Andes WA, Chavin SI, Beltran G, Stuckey WJ.

Thromb Res. 1982 Jan 1-15;25(1-2):41-50.

PMID:
6801812
20.

Molecular characterization of an abnormal fibrinogen by two-dimensional electrophoresis.

Polack B, Valiron O, Concord E, Freyssinet JM, Hudry-Clergeon G.

Clin Chem. 1984 Dec;30(12 Pt 1):2093-7.

Supplemental Content

Support Center